Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The SURMOUNT-1 trial enrolled 2,539 patients with obesity, excluding individuals with diabetes or uncontrolled hypertension, and randomized them to placebo or 5, 10, or 15 mg of tirzepatide
You might think you are just tipsy when your blood sugar is actually crashing
Report any side effects to your trial clinician promptly
.png)
Some providers use 5 mg as a starting dose for patients on high-dose semaglutide, but this increases nausea risk and is not supported by published protocols
And what will that mean for Eli Lilly and Novo Nordisk
2020;9:e50260
US$ 23.95
US$ 21.50
US$ 20.11
